Syndax Pharmaceuticals (SNDX) FCF Margin (QoQ) (2015 - 2026)
Syndax Pharmaceuticals (SNDX) FCF Margin (QoQ) (2015 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Syndax Pharmaceuticals |
1.69 Bn |
1.34 Bn |
53.02 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
2,357.00 |
| Dec 31, 2025 |
5,258.00 |
| Sep 30, 2025 |
7,753.00 |
| Jun 30, 2025 |
24,352.00 |
| Mar 31, 2025 |
27,243.00 |
| Dec 31, 2024 |
-24,866.00 |
| Sep 30, 2024 |
154,842.00 |
| Dec 31, 2021 |
28,113.00 |
| Sep 30, 2021 |
614,276.00 |
| Jun 30, 2021 |
-38,417.00 |
| Mar 31, 2021 |
-184,674.00 |
| Dec 31, 2020 |
71,428.00 |
| Sep 30, 2020 |
82,058.00 |
| Jun 30, 2020 |
-144,644.00 |
| Mar 31, 2020 |
-85,264.00 |
| Dec 31, 2019 |
-109,881.00 |
| Sep 30, 2019 |
105,435.00 |
| Jun 30, 2019 |
113,615.00 |
| Mar 31, 2019 |
-47,853.00 |
| Dec 31, 2018 |
91,072.00 |
